Reactive oxygen species production by blood leukocytes and its correction by trimetazidine MB in patients with acute coronary syndrome
Aim. In patients with acute coronary syndrome (ACS), to detect pre-activated (primed) phagocytes in peripheral blood and to evaluate the effects of trimetazidine MB, when added to standard therapy, on reactive oxygen species (ROS) production. Material and methods. In 113 hospitalised ACS patients –...
Saved in:
| Main Authors: | M. G. Glezer, S. V. Kulikov, R. T. Saygitov, E. I. Astashkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2009-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01) -
Personalized trimetazidine prescription as a cytoprotective agent in patients with coronary artery disease
by: O. V. Romashchenko
Published: (2021-07-01) -
Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01) -
Trimetazidine effects on mitochondria energetic activity
by: S. V. Eliseeva, et al.
Published: (2008-12-01) -
New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)